APLS Past Earnings image Apellis Pharmaceuticals Past Earnings

APLS Past Earnings

— Presenting past earnings and revenue for Apellis Pharmaceuticals (APLS) from Q4 2017 to Q1 2026, based on our latest update on 5/18/2026. The past earnings numbers are per-share values while the revenue is the grand total for the quarter. Studying these APLS past earnings numbers both in chart format and in tables can help investors visualize any typical seasonality patterns, as well as determine whether the company has grown over time.
Quick links: Past Earnings  |  Past Revenue  |  FAQ
APLS Past Earnings
PeriodPast Earnings DateGAAP
Q1 20265/7/20260.150
Q4 20252/24/2026-0.470
Q3 202510/30/20251.670
Q2 20257/31/2025-0.330
Q1 20255/7/2025-0.740
Q4 20242/28/2025-0.290
Q3 202411/5/2024-0.460
Q2 20248/1/2024-0.280
Q1 20245/7/2024-0.540
Q4 20232/27/2024-0.730
Q3 202311/1/2023-1.170
Q2 20237/31/2023-1.020
Q1 20235/4/2023-1.560
Q4 20222/21/2023-1.500
Q3 202211/7/2022-1.750
Q2 20228/8/2022-1.460
Q1 20225/4/2022-1.420
Q4 20212/28/2022-1.610
Q3 202111/8/2021-1.570
Q2 20218/9/2021-2.720
Q1 20214/28/2021-2.320
Q4 20202/25/20210.930
Q3 202011/2/2020-1.790
Q2 20207/31/2020-1.570
Q1 20204/29/2020-2.290
Q4 20192/27/2020-1.770
Q3 201911/5/2019-1.090
Q2 20197/31/2019-1.120
Q1 20195/8/2019-0.870
Q4 20182/26/2019-0.65
Q3 201811/13/2018-0.64
Q2 20187/31/2018-0.61
Q1 20184/30/2018-0.43
Q4 20173/19/2018-0.61
APLS Past Revenue
PeriodPast Earnings DateGAAP
Q1 20265/7/20260.27B
Q4 20252/24/20260.20B
Q3 202510/30/20250.46B
Q2 20257/31/20250.18B
Q1 20255/7/20250.17B
Q4 20242/28/20250.21B
Q3 202411/5/20240.20B
Q2 20248/1/20240.20B
Q1 20245/7/20240.17B
Q4 20232/27/20240.15B
Q3 202311/1/20230.11B
Q2 20237/31/20230.09B
Q1 20235/4/20230.04B
Q4 20222/21/20230.02B
Q3 202211/7/20220.02B
Q2 20228/8/20220.02B
Q1 20225/4/20220.01B
Q4 20212/28/20220.06B
Q3 202111/8/20210.01B
Q2 20218/9/20210.00B
Q1 20214/28/2021NA
Q4 20202/25/20210.25B
Q3 202011/2/20200.00B
Q2 20207/31/2020NA
Q1 20204/29/2020NA
Q4 20192/27/2020NA
Q3 201911/5/2019NA
Q2 20197/31/2019NA
Q1 20195/8/2019NA
Q4 20182/26/2019NA
Q3 201811/13/2018NA
Q2 20187/31/2018NA
Q1 20184/30/2018NA
Q4 20173/19/2018NA
Quotes delayed 20 minutes

Email EnvelopeFree APLS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Apellis Pharmaceuticals (APLS) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

APLT Past Earnings
APR Past Earnings
APRE Past Earnings
APTX Past Earnings
APVO Past Earnings
APYX Past Earnings
AQST Past Earnings
ARAV Past Earnings
ARAY Past Earnings
ARCT Past Earnings

APLS Past Earnings Q&A

What was the best and worst APLS past earnings results?
For Apellis Pharmaceuticals, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest APLS past earnings result in our data set was 1.670/share posted in Q3 2025, while the lowest was in Q2 2021 when APLS posted -2.720/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q3 2025 when APLS reported 0.46B in revenue, while the quarter with the lowest revenue in our data set was Q1 2021 at NA of revenue.

  Suggested answer: There are 34 APLS past earnings results in our data set.

On this page we presented the APLS past earnings date information for Apellis Pharmaceuticals. Reviewing that APLS Past Earnings for the company, we see that the highest past earnings result in our data set was in Q3 2025, when APLS posted gaap of 1.670/share. Meanwhile the lowest APLS past earnings result was in Q2 2021, when APLS posted gaap of -2.720/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q3 2025 when APLS reported 0.46B in revenue, while the smallest revenue quarter was Q1 2021 when APLS reported NA in revenue.

Any self directed investor doing their due diligence on APLS or any other given stock can benefit from researching all of the Apellis Pharmaceuticals past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Apellis Pharmaceuticals past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for APLS. Thanks for visiting, and the next time you need to research APLS past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.
 

APLS Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2026, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.